Muopolysaccharidosis Type I Skeletal Alterations and Cross Correction in an Ex Vivo Gene Therapy Approach

被引：0

作者：

Santi, Ludovica ^{[1
]}

Crippa, Stefania ^{[1
]}

Capo, Valentina ^{[1
]}

Penna, Sara ^{[1
]}

De Ponti, Giada ^{[1
]}

Alberti, Gaia ^{[1
]}

Berti, Margherita ^{[1
]}

Basini, Tommaso ^{[1
]}

Consiglieri, Giulia ^{[2
]}

Tucci, Francesca ^{[2
]}

Riminucci, Mara ^{[3
]}

Corsi, Alessandro ^{[3
]}

Barbero, Andrea ^{[4
]}

Lopa, Silvia ^{[5
]}

Martin, Ivan ^{[4
]}

Moretti, Matteo ^{[5
]}

Gentner, Bernhard ^{[1
]}

Aiuti, Alessandro ^{[1
]}

Villa, Anna ^{[1
]}

Bernardo, Maria Ester ^{[1
]}

机构：

[1] San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy

[2] Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy

[3] Sapienza Univ, Dept Mol Med, Rome, Italy

[4] Tissue Engn Dept Biomed, Basel, Switzerland

[5] Cell & Tissue Engn Lab, Milan, Italy

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1514

引用

页码：712 / 713

页数：2

共 50 条

[21] Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
Alessandro Fraldi
Marta Serafini
Nicolina Cristina Sorrentino
Bernhard Gentner
Alessandro Aiuti
Maria Ester Bernardo
Italian Journal of Pediatrics, 44
[22] Skeletal damage and cross-correction in MPSIH HSPC-gene therapy
Santi, L.
Crippa, S.
Capo, V.
Penna, S.
De Ponti, G.
Berti, M.
Mancino, M.
Tucci, F.
Riminucci, M.
Corsi, A.
Serafini, M.
Barbero, A.
Lopa, S.
Martin, I.
Moretti, M.
Gentner, B.
Aiuti, A.
Villa, A.
Bernardo, M. E.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A3 - A4
[23] The role of cell type in bone healing mediated by ex vivo gene therapy
Rose, T
Peng, HR
Shen, HC
Usas, A
Kuroda, R
Lill, H
Fu, FH
Huard, J
LANGENBECKS ARCHIVES OF SURGERY, 2003, 388 (05) : 347 - 355
[24] The role of cell type in bone healing mediated by ex vivo gene therapy
Tim Rose
Hairong Peng
Hsain-Chung Shen
Arvydas Usas
Ryosuke Kuroda
Helmut Lill
Freddie H. Fu
Johnny Huard
Langenbeck's Archives of Surgery, 2003, 388 : 347 - 355
[25] Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1
Ates, Ilayda
Stuart, Callie
Rathbone, Tanner
Barzi, Mercedes
He, Gordon
Major, Angela M.
Shankar, Vijay
Lyman, Rachel A.
Angner, Sidney S.
Mackay, Trudy F. C.
Srinivasan, Shanthi
Farris, Alton Brad
Bissig, Karl-Dimiter
Cottle, Renee N.
HEPATOLOGY COMMUNICATIONS, 2024, 8 (05)
[26] EX VIVO GENE THERAPY APPROACH BY TARGT TECHNOLOGY FOR THE TREATMENT OF β - THALASSEMIA INTERMEDIA
Casu, Carla
Lo Presti, Vania
O'Hara, Emir
Neil, Garry
Miari, Reem
Shapir, Nir
Rivella, Stefano
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E427 - E427
[27] Ex Vivo Gene Therapy Approach By Targt Technology for the Treatment of β-Thalassemia Intermedia
Casu, Carla
Lo Presti, Vania
O'Hara, Emir M.
Neil, Garry
Miari, Reem
Shapir, Nir
Rivella, Stefano
BLOOD, 2016, 128 (22)
[28] Gene editing for ex vivo pachyonychia congenita correction
Diez, M. Garcia
Sot, B.
Moreno, M.
Morin, M.
Soletto, L.
Fernandez, S.
Prado, D.
Murillas, R.
Mencia, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S149 - S149
[29] Ex vivo gene therapy for Fabry disease
Fallet, S.
Mason, C.
Kreher, N. C.
HUMAN GENE THERAPY, 2018, 29 (12) : A124 - A124
[30] New Approaches towards ex vivo and in vivo gene therapy
Hauser, H
Spitzer, D
Verhoeyen, E
Unsinger, J
Wirth, D
CELLS TISSUES ORGANS, 2000, 167 (2-3) : 75 - 80

← 1 2 3 4 5 →